| Product Name | LRIG1 |
|---|---|
| Antibody Type | Primary Antibodies |
| Product description | domain:The LRRs and the Ig-domains are each sufficient for EGFR/ERBB1 binding. This interaction is abolished only when these two domains are deleted. Act as a feedback negative regulator of signaling by receptor tyrosine kinases, through a mechanism that involves enhancement of receptor ubiquitination and accelerated intracellular degradation. induction:By EGF. Contains 17 LRR (leucine-rich) repeats. Contains 3 Ig-like C2-type (immunoglobulin-like) domains. subunit:Interacts with EGFR/ERBB1, ERBB2, ERBB3 and ERBB4. tissue specificity:Widely expressed. |
| Immunogen | Synthesized peptide derived from part region of human protein |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:500-1:2000 |
|
| Species Reactivity | HumanMouse |
| Concentration | 1mg/ml |
| Molecular Weight(MW) | 120 kDa |
|---|
| SwissProt ID | Q96JA1 |
|---|
| Positive Control | Lymph,Placenta,Uterus, |
|---|---|
| Application Notes | WB:1:500-1:2000 |
| Form | Liquid |
|---|---|
| Storage Instructions | Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles. |
| Storage Buffer | Liquid in PBS containing 50% glycerol, and 0.02% sodium azide. |
